EIDD - 2801 is RNA analogues EIDD - 1931 before medicine orally bioavailable.
EIDD - 2801 for influenza viruses and a variety of coronavirus (for example SARS - CoV - 2, MERS - CoV, SARS - CoV) of broad-spectrum antiviral activity.
EIDD - 2801 with treatment of COVID - 19 and the potential of seasonal and pandemic influenza.
EIDD-2801 (Molnupiravir) is an oral antiviral nucleoside analog designed for broad-spectrum activity against RNA viruses. The core synthesis involves enzymatic conversion of cytidine to the beta-D-N4-hydroxycytidine derivative. Molecular Formula: C9H13N3O5; CAS No: 768398-88-1.
Strictly contraindicated during pregnancy due to potential teratogenicity and mutagenic risks. Storage requires controlled room temperature (20-25°C) in moisture-proof, light-resistant containers with strict inventory segregation from food products.